Molecular profiling of extracellular vesicles via charge-based capture using oxide nanowire microfluidics
Molecular profiling of extracellular vesicles via charge-based capture using oxide nanowire microfluidics
复制标题
使用氧化物纳米线微流体通过基于电荷的捕获对细胞外囊泡进行分子分析
DOI:
10.1016/j.bios.2021.113589
复制
发表时间:
2021
影响因子:
12.6
通讯作者:
Baba Yoshinobu
中科院分区:
文献类型:
--
作者:
Yasui Takao;Paisrisarn Piyawan;Yanagida Takeshi;Konakade Yuki;Nakamura Yuta;Nagashima Kazuki;Musa Marina;Thiodorus Ivan Adiyasa;Takahashi Hiromi;Naganawa Tsuyoshi;Shimada Taisuke;Kaji Noritada;Ochiya Takahiro;Kawai Tomoji;Baba Yoshinobu
Extracellular vesicles (EVs) have shown promising features as biomarkers for early cancer diagnoses. The outer layer of cancer cell-derived EVs consists of organotropic metastasis-induced membrane proteins and specifically enriched proteoglycans, and these molecular compositions determine EV surface charge. Although many efforts have been devoted to investigating the correlation between EV subsets obtained through density-, size-, and immunoaffinity-based captures and expressed membrane proteins, understanding the correlation between EV subsets obtained through surface charge-based capture and expressed membrane proteins is lacking. Here, we propose a methodology to profile membrane proteins of EV subsets obtained through surface charge-based capture. Nanowire-induced charge-based capture of EVs andin-situprofiling of EV membrane proteins are the two key methodology points. The oxide nanowires allowed EVs to be obtained through surface charge-based capture due to the diverse isoelectric points of the oxides and the large surface-to-volume ratios of the nanowire structures. And, with the ZnO nanowire device, whose use does not require any purification and concentration processes, we demonstrated the correlation between negatively-charged EV subsets and expressed membrane proteins derived from each cell. Furthermore, we determined that a colon cancer related membrane protein was overexpressed on negatively charged surface EVs derived from colon cancer cells.